News
Showing for 1 to 10 of 25 available entries.RSS
Category filter
-
Institutional
3 May 2013
The Endocrinologist Manel Puig Domingo is the new Director of the Health Sciences Research Institute of the Germans Trias i Pujol Foundation (IGTP)
Dr Puig is taking over from Dr Miguel Àngel Gassull, director of the IGTP until now. Dr Gassull will now be managing the areas of Innovation and European Projects for the institute.
-
Research
22 April 2013
Two new Reviews Published by the Buschbeck Laboratory
The Buschbeck laboratory at the Institute of Predictive and Personalized Medicine of Cancer (IMPPC) have published two reviews on an important element of chromatin, the structure that packages DNA in cells and controls its function.
-
Institutional
11 April 2013
The Agreement is Signed for the Construction of the new Josep Carreras Institute - Clinic-UB Campus
Josep Carreras, President of the Josep Carreras Leukaemia Research Institute (IJC) and the International Josep Carreras Foundation, Dídac Ramirez, Rector of the University of Barcelona (UB)and Albert Carreras, acting for the IJC, signed the agreement that will make a new campus possible.
-
Institutional
18 March 2013
IV Annual Conference Declared a Great Success
The fourth annual conference has been the most successful yet; over 300 delegates attended over the two full days to hear 22 international speakers. Eduard Serra for the IMPPC organized the event with Gabriel Capellá, Ignacio Blanco and Conxi Lázaro of the Hereditary Cancer Program of the Catalan Institute of Oncology (ICO).
-
Research
19 February 2013
The Badalona mutation discovered by IMPPC researchers
The unit for advanced genetic diagnosis for rare iron metabolism diseases (UDGAEMH) in the Institute of Predictive and Personalized Medicine of Cancer (IMPPC) led by Dr. Mayka Sanchez has discovered a new mutation, the Badalona mutation, causing hereditary hyperferritinemia with cataracts syndrome (HHCS) in a Spanish family. This new mutation, along with previously discovered mutations, can be identified by genetic testing and allow the disease to be correctly diagnosed. Sometimes cases of HHCS have been confused with another genetic disease, Hereditary Hemochromatosis, which leads to the wrong treament being given to patients.
-
Research
27 January 2013
A new "Disease-in-a-dish" model for Hereditary ARVD/C
Sònia Forcales of the Genetics and Epigenetics of Cancer group led by Manuel Perucho at the Institute of Predictive and Personalized Medicine of Cancer (IMPPC) has participated in a study published on-line in Nature today. The study was collaboration between researchers of the Sanford Burnham Institute for Medical Research and the Johns Hopkins University.
-
Research
13 December 2012
Fumiichiro Yamamoto and the ABO Histo-blood Groups and Cancer Laboratory discover the molecular genetic basis of the human Forssman glycolipid antigen negativity
In a paper published today in Scientific Reports the Yamamoto group resolves a classic question in Glycobiology. The heterophilic Forssman glycolipid antigen has a structural similarity to the histo-blood group A antigen and the GBGT1 gene that codes for the Forssman glycolipid synthetase (FS) is evolutionarily related to the ABO gene. Dr Yamamoto is well known for his ground-breaking work on defining the genetics behind the ABO blood groups, and this current work clarifies the functioning of the second in the family of four closely related genes, which specifies the expression of the Forssman antigen.
-
Research
28 November 2012
Human genes with CpG island promoters have a distinct transcription-associated chromatin organization
Tanya Vavouri, Junior Group Leader at the IMPPC has just published her first paper for the IMPPC in Genome Biology. The paper, co-authored with Ben Lehner of the Genetic Systems group at the CRG, describes how the type of promoter in which transcription is initiated influences the chromatin of human genes.
-
Research
5 September 2012
Two new studies by the Genetic Variation and Cancer Group published
Two new papers highlight aspects of the research performed by the group. One describes a new methodology for the genetic analysis of tumors and the ...
-
Institutional
7 July 2012
First Stone Laid for the Josep Carreras Leukaemia Research Institute
The first stone of the new building of the Josep Carreras Leukemia Research Institute was laid on Saturday 7 July. The new building will be next to the IMPPC in the grounds of the Germans Trias i Pujol University Hospital.
